Arindom Sen

2.4k citations
68 papers · 1.9k indexed · h-index 24

Arindom Sen

68 papers receiving 1.8k citations

Peers

Arindom Sen
Comparison fields: 5 of 125
  • Genetics 486
  • Developmental Neuroscience 159
  • Molecular Biology 949
  • Biomedical Engineering 597
  • Biomaterials 176
Replace Michael S. Kallos with:
Michael S. Kallos Canada
Ben A. Scheven United Kingdom
Stefan Arnhold Germany
Guangqian Zhou China
Michael Wöltje Germany
Wenxue Zhao China
Maria Szymonowicz Poland
David García‐Bernal Spain
Yuji Yasunaga Japan
Arindom Sen relative to Michael S. Kallos Canada Michael S. Kallos's profile →
Citations per field
00.5×1.6×
Michael S. Kallos · 1×
Citations per year

Countries citing papers authored by Arindom Sen

Since Specialization
Citations

This map shows the geographic impact of Arindom Sen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arindom Sen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arindom Sen more than expected).

Fields of papers citing papers by Arindom Sen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arindom Sen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arindom Sen. The network helps show where Arindom Sen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arindom Sen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arindom Sen Line = papers co-authored together Arindom Sen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 202312
3 202316
4 202318
5 202160
6 20217
7 201922
8 20198
9 201916
10 201819
11 201614
12 201520
13 201319
14 201221
15 201111
16 201141
17 201088
18 200529
19 200426
20 200236

About Arindom Sen

Arindom Sen is a scholar working on Developmental Neuroscience, Genetics and Cellular and Molecular Neuroscience, having authored 68 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (17 papers), Mesenchymal stem cell research (16 papers), Neurogenesis and neuroplasticity mechanisms (12 papers), Nerve injury and regeneration (10 papers), 3D Printing in Biomedical Research (9 papers), Tissue Engineering and Regenerative Medicine (8 papers), Extracellular vesicles in disease (6 papers) and Intracranial Aneurysms: Treatment and Complications (5 papers). The work is most often cited by research in Genetics (486 citations), Developmental Neuroscience (159 citations) and Molecular Biology (949 citations). Arindom Sen has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Leo A. Behie, Michael S. Kallos, Amir Sanati‐Nezhad, Lawrence Rosenberg, Ian D. Gates, Sunghoon Jung, Neil A. Duncan, Mark Ungrin, David A. Hart and Murray Hong. Their work appears in journals such as Biotechnology and Bioengineering, Biotechnology Progress, The Canadian Journal of Chemical Engineering, Journal of Tissue Engineering and Regenerative Medicine and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026